Compare APT & DXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | APT | DXR |
|---|---|---|
| Founded | 1983 | 1970 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 53.3M | 59.0M |
| IPO Year | 1997 | 1995 |
| Metric | APT | DXR |
|---|---|---|
| Price | $5.34 | $10.40 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 31.3K | 8.7K |
| Earning Date | 05-08-2026 | 02-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.24 | N/A |
| Revenue | ★ $59,142,000.00 | $1,446,345.00 |
| Revenue This Year | N/A | $44,935.22 |
| Revenue Next Year | N/A | $74.79 |
| P/E Ratio | ★ $22.00 | $33.83 |
| Revenue Growth | ★ 2.25 | N/A |
| 52 Week Low | $4.34 | $8.56 |
| 52 Week High | $7.50 | $14.76 |
| Indicator | APT | DXR |
|---|---|---|
| Relative Strength Index (RSI) | 52.25 | N/A |
| Support Level | $5.13 | N/A |
| Resistance Level | $5.35 | N/A |
| Average True Range (ATR) | 0.16 | 0.00 |
| MACD | -0.01 | 0.00 |
| Stochastic Oscillator | 41.68 | 0.00 |
Alpha Pro Tech Ltd is in the business of protecting people, products, and environments. It is developing, manufacturing, and marketing a line of disposable protective apparel and infection control products for the cleanroom, industrial, pharmaceutical, medical, and dental markets. It also manufactures a line of building supply construction weatherization products that are sold under the Alpha Pro Tech brand name. The Company operates through two business segments: Building Supply and Disposable Protective Apparel. Key revenue is generated from Building Supply, consisting of a line of construction supply weatherization products. The construction supply weatherization products consist of housewrap and synthetic roof underlayment, and synthetic roof underlayment accessories.
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA offers unmatched, real-time, precise data via its rapid, hand-held, lab-based system.